Publication Date:
2017-04-08
Description:
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells Scientific Reports, Published online: 7 April 2017; doi:10.1038/s41598-017-00462-8
Electronic ISSN:
2045-2322
Topics:
Natural Sciences in General
Permalink